Inhibition of NF-κB by genetic knockdown or chemical inhibitors has been shown to decrease cancer cell proliferation, migration, invasion, and metastasis and to reduce the chemoresistance of cancer cells to anticancer drugs [9, 10]. Here, NFKB1 is linked to cancer.